Home » Newsletters » BioWorld Science

BioWorld Science

June 11, 1999

View Archived Issues

Pharmacokinetics of sustained-release oral zidovudine tested

BTG: positive progress in the year to March 31, 1999

Data from phase I/II study of NBI-3001 presented at German Society of Neurosurgery

FDA advisory committee recommends approval of Ellence breast cancer treatment

LY-294002 induces apoptosis alone or in combination with other apoptosis-inducing agents

Biomira discusses Theratope progress at annual general meeting

Selective Genetics and Biomet form alliance for orthopedic therapy

Scios and Bayer end commercial alliance for Natrecor

U.K. is first European country to approve Vioxx for marketing; U.S. introduction announced

ViroPharma continues to search for new solutions to viral disease in 1998

Planned enrollment complete for IntraDose trial, additional patients included

Amrad reports disappointing results of phase II trial evaluating RSV vaccine

BTS-71091 induces satiety in rats

Cannabinoid receptor antagonist SR-141716 shows potential as antiobesity agent

Antifungal peptides with low toxicity described by Morinaga

Japanese patents cover Daiichi's new diphenyl antitumor agents

Novel, broad-spectrum macrolides in development at Pfizer

Sankyo prepares and tests new HIV protease inhibitor

D-Proline derivatives for amyloidosis disclosed by Roche

Antidiabetic compound effectively treats obesity in patients with altered glucose metabolism

Experimental peptide vaccine is safe and effective in patients with CML

Pyridylether derivatives and use as nAChR ligands

Nippon Kayaku launches new treatment for heart failure in Japan

Spongistatin-like cytotoxic agents developed at U. of Pennsylvania

Bcr-Abl kinase inhibitor CGP-57148B featured at hematology meeting

Amgen reveals potent and selective typtase-inhibitory series

Chinese herb provides significant benefit in mouse model of SLE

ATTRACT trial demonstrates long-term efficacy and safety of Remicade in RA

Major licensing agreement announced for former IDEC-Y2B8

Oral vitamin D prohormone cleared by the FDA for secondary hyperparathyroidism

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026